SentiAR Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $5.6M
Latest Deal Amount
  • Investors
  • 14

SentiAR General Information

Description

Developer of a 3D augmented reality platform designed to transform the experience for both patients and clinicians in interventional procedures. The company's platform features real-time holographic visualization of the patient's actual anatomy and utilizes a hands-free, head-up display to change the way data and imaging results are displayed in the operating room, enabling clinicians to treat and analyze cardiac arrhythmias within an interventional catheter lab environment.

Contact Information

Website
www.sentiar.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Other Hardware
Other Healthcare Technology Systems
Primary Office
  • 212 Kingshighway Boulevard
  • Suite 115
  • Saint Louis, MO 63108
  • United States
+1 (314) 000-0000

SentiAR Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SentiAR Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC (Series A) 01-Jan-2021 $5.6M 00.00 000.00 Completed Generating Revenue
5. Seed Round 16-Apr-2018 000 00.00 Completed Generating Revenue
4. Early Stage VC (Series A) 22-Feb-2018 000 Cancelled Product In Beta Test
3. Grant 15-Jan-2018 00.00 00.00 Completed Product In Beta Test
2. Grant 03-Nov-2017 $595K $1.1M Completed Product In Beta Test
1. Seed Round 31-Aug-2017 $1.1M $1.1M Completed Product In Beta Test
To view SentiAR’s complete valuation and funding history, request access »

SentiAR Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A-3 000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series A-2 658,080 $0.000010 6% $1.67 $1.67 1x $1.67 13.43%
Series A-1 157,042 $0.000010 6% $1.91 $1.91 1x $1.91 3.21%
To view SentiAR’s complete cap table history, request access »

SentiAR Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a 3D augmented reality platform designed to transform the experience for both patients and clinicians in in
Monitoring Equipment
Saint Louis, MO
11 As of 2021
00.00
00.00 0000-00-00
00000000000 00.00

00000000

te irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Exce
00000 0000000000 0000000000 0000000
Yokneam, Israel
00 As of 0000
000.00
00000000000 000.00

00000000

itation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehende
0000000000 000000000
Santa Clara, CA
00 As of 0000
000.00
000000000 - 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SentiAR Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
RealView (Other Healthcare Technology Systems) Venture Capital-Backed Yokneam, Israel 00 000.00 00000000000 000.00
000000000 Venture Capital-Backed Santa Clara, CA 00 000.00 000000000 - 000.00
0000000 Venture Capital-Backed New York, NY 00 00.000 0000000000 0 00.000
00000000 Venture Capital-Backed London, United Kingdom 00 000.00 00000000000 000.00
0000000000000 Venture Capital-Backed London, United Kingdom 00 00.00 00000000000 00.00
You’re viewing 5 of 7 competitors. Get the full list »

SentiAR Executive Team (5)

Name Title Board Seat Contact Info
Berk Tas Chief Executive Officer, President & Board Member
Jonathan Silva Co-Founder, Chief Technology Officer & Board Member
Michael Southworth Co-Founder, Lead Developer & Vice President of Technology
Jennifer Silva MD Co-Founder, Chief Medical Officer & Board Member
You’re viewing 4 of 5 executive team members. Get the full list »

SentiAR Board Members (7)

Name Representing Role Since
Berk Tas SentiAR Chief Executive Officer, President & Board Member 000 0000
Charles Bolten BioGenerator Board Member 000 0000
Jennifer Silva MD SentiAR Co-Founder, Chief Medical Officer & Board Member 000 0000
Jonathan Silva SentiAR Co-Founder, Chief Technology Officer & Board Member 000 0000
Shlomo Shpun Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

SentiAR Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SentiAR Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Harmonix Fund Venture Capital Minority 000 0000 000000 0
Keiretsu Forum Venture Capital Minority 000 0000 000000 0
Militello Capital PE/Buyout Minority 000 0000 000000 0
Service Provider Capital Venture Capital Minority 000 0000 000000 0
Techwald Holding Corporation Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »